Similar Items: Diagnostic accuracy of novel sputum and non-sputum-based tuberculosis diagnostics in HIV-positive patients initiating anti-retroviral therapy
- Novel and rapid tests for diagnosis of tuberculosis using non-sputum specimens
- Sputum derived biomarkers of anti-tuberculosis drug activity in early bactericidal activity (EBA) studies
- Analysis of ex vivo host biomarkers in sputum samples for diagnosis of pulmonary tuberculosis
- Automated sputum screening using the BD FocalPointTM Slide Profiler : correlation with transbronchial and transthoracic needle aspirates in a high risk population
- recovery rates of mycobacterium tuberculosis using five decontamination methods
- The microbiome and inferred function in pulmonary and extrapulmonary tuberculosis.
Author: Theron, Grant
- Accuracy and impact of the MTBDRplus v2 and MTBDRsl v2 line probe assays for the detection of first-line and second-line drug resistant tuberculosis
- Novel and rapid tests for diagnosis of tuberculosis using non-sputum specimens
- Resistance to new tuberculosis drugs
- Characterisation of phenotypic and genotypic resistance to new and re-purposed tuberculosis drugs in the Western Cape, South Africa
- Novel approaches for the diagnosis of drug-resistance, treatment response, and infectiousness in patients with tuberculosis (the eDIToR study – Diagnosis Infectiousness and Treatment Response)
- The respiratory and gut microbiota in pulmonary tuberculosis